Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-011986
Filing Date
2025-08-14
Accepted
2025-08-14 16:15:52
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1165690
2 EX-10.1 ex10-1.htm EX-10.1 16373
3 EX-31.1 ex31-1.htm EX-31.1 19008
4 EX-31.2 ex31-2.htm EX-31.2 18552
5 EX-32.1 ex32-1.htm EX-32.1 7329
6 EX-32.2 ex32-2.htm EX-32.2 7234
  Complete submission text file 0001493152-25-011986.txt   6171090

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aimi-20250630.xsd EX-101.SCH 44769
8 XBRL CALCULATION FILE aimi-20250630_cal.xml EX-101.CAL 54033
9 XBRL DEFINITION FILE aimi-20250630_def.xml EX-101.DEF 218425
10 XBRL LABEL FILE aimi-20250630_lab.xml EX-101.LAB 371342
11 XBRL PRESENTATION FILE aimi-20250630_pre.xml EX-101.PRE 300835
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 920689
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 251219364
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)